BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS - Soverini, Simona; Martelli, Margherita; Bavaro, Luana; De Benedittis, Caterina; Sica, Simona; Sorà, Federica; Iurlo, Alessandra; Bonifacio, Massimiliano; Pregno, Patrizia; Galimberti, Sara; Lunghi, Francesca; Albano, Francesco; et al. (Leukemia, 2021)
Keywords: 38/23; 631/67/1990/283/1896; 631/67/1990/283/2125; Acute lymphocytic leukemia; BCR-ABL tyrosine kinase inhibitors; Cancer Research; Chromosomes; Critical Care Medicine; Development and progression; Drug resistance; Drug therapy; Enzyme inhibitors; Gene mutations; Genetic aspects; Hematology; Intensive; Internal Medicine; Kinases; Letter; Leukemia; Leukemia research; Medicine; Medicine & Public Health; Mutation; Oncology; Patients; Philadelphia chromosome; Physiological aspects; Tyrosine; Tyrosine kinase inhibitors; Italy